Monday June 30, 2008

8:30 Registration at Welcome Desk

8:45 SSIF Opening
Giancarlo Comi, Italy

09:00 Opening and introduction to the MS Clinic. Setting the scene
Xavier Montalban, Spain

9:30 Epidemiology, social burden and costs of MS
Speaker to be confirmed

10:00 Environmental factors
Mireia Sospedra, Germany

10:30 Coffee break

11:00 Genomics and systems biology in MS
Pablo Villoslada, Spain

11:45 Patterns of disease
Oscar Fernandez, Spain

12:15 DMDs and pregnancy
Magnhild Sandberg-Wollheim, Sweden

12:45 Juvenile MS
Speaker to be confirmed

13:15 Lunch

14:30-16:30 Visiting the premises of the UNIC – Clinical Neuroimmunology Unit

Session “Clinical”: including visits and practices in the Ambulatories and Psychological offices. (Inside the Vall d’Hebron Hospital).

Session “MRI”: the group follows a real MRI evaluation of a patient and discuss with the tutor methodology, findings and final results. (Inside the Vall d’Hebron Hospital).

Session “Lab”: the group follows the tutor in the Laboratories and he/she will show different technical equipments and the importance of collaboration networks involving other centres. (Inside the Vall d’Hebron Hospital).

Session “Rehabilitation”: the group follows the tutor in the rehabilitation setting in order to analyze different approach related to different stages of the disease. (Groups will go outside the hospital to visit the FEM – Rehabilitation centre).

16:30 Coffee break

16:45 MS diagnosis and differential diagnosis
Mar Tintoré, Spain

17:15 MRI. Monitoring disease activity. Non conventional MRI
Álex Rovira, Spain

17:45 Pathogenesis of MS and therapeutic targets
Roland Martin, Germany

18:15 End of Day 1

Tuesday July 1, 2008

09:00 Management of Relapses 
Carlos Nos, Spain

09:30 Symptomatic treatment
Jaume Sastre-Garriga, Spain

10:00 “On demand” case study session
Topic 1 - Carlos Nos, Spain
Topic 2 – Jaume Sastre-Garriga, Spain
Topic 3 – Neus Tellez, Spain

11:00 Coffee break

11:30 Cognition in MS. Overview
Maria Pia Amato, Italy

12.00 Emotional disturbances in MS
Maria Jesus Arevalo, Spain

12:30 Working lunch

14:00 Visiting the premises of the UNIC – Clinical Neuroimmunology Unit

16:00 Coffee break

16:30 Definition of response to treatment
Jordi Rio, Spain

17:00 Factors influencing treatment response: NAbs and pharmacogenetics
Manuel Comabella, Spain

17:45 End of Day 2

Wednesday July 2, 2008

09:00 DMDs in MS: the cornerstone of knowledge
Giancarlo Comi, Italy

09:20  Advantages of early treatment in MS
Xavier Montalban, Spain

09:40 DMDS in MS: observational studies
Speaker to be confirmed

10:00 Long-term Data
Xavier Montalban, Spain

10:20 Coffee break

10:40 Panel Discussion on present treatments
Moderator: Jaume Sastre-Garriga, Spain

Speaker to be confirmed
Giancarlo Comi, Italy
Xavier Montalban, Spain

11:15 Future Therapies
Giancarlo Comi, Italy

11:45 How to optimize treatment and compliance to treatment
Jaume Sastre-Garriga and Maria Jesus Arevalo, Spain

12:15 How to increase compliance improving the interaction with the patient: a role-playing
Jaume Sastre-Garriga and Maria Jesus Arevalo, Spain

12:45 Lunch

14:00-15:00  Case study on DMDs efficacy - Lluís Ramió, Spain
Case study on DMDs safety – Ester Moral, Spain
Case study on early treatment – speaker to be confirmed

15:00 Concluding remarks
Xavier Montalban, Spain